Viewing nowCombinationAmdikabq 30/2.5 mg Tablets
Fimasartan Potassium Trihydrate 33.005mg · S-Amlodipine Besylate 2.5 Hydrate 3.74mg
Tablet · Prescription medication · Combination
Youngpoong Pharmaceutical Co., Ltd.

MFDS item code 202300141 · Approved 2023.01.06 · Insurance code 661905770
Improvement of blood pressure control in essential hypertension
This medication helps to lower blood pressure more effectively in patients with essential hypertension who are not sufficiently controlled on monotherapy with pimodivir potassium. It is used to improve blood pressure control and reduce the risk of cardiovascular disease.
The recommended dosage of this medication is one tablet once a day, taken with water regardless of meals. It is recommended to take it at the same time each day (e.g. morning). Elderly patients (under 70 years) do not require initial dose adjustment. Patients with mild to moderate kidney impairment (creatinine clearance 30-80 mL/min) do not require dosage adjustment, however, in patients with severe impairment (creatinine clearance < 30 mL/min), treatment with 30 mg of pimodivir should be initiated.
Safety and efficacy in pediatric and adolescent patients under 18 years of age have not been established.
This medication can cause serious harm to the fetus and newborn if taken during pregnancy, especially in the second and third trimesters, so it should be discontinued immediately upon confirmation of pregnancy. Patients with allergies to the ingredients of this medication, certain kidney diseases, liver dysfunction, biliary obstruction, and certain genetic metabolic disorders should not take this medication. Patients with depleted blood volume or sodium, impaired kidney function, renal artery hypertension, etc. should be cautious, as hypotension or worsening of kidney function may occur when taking this medication. Side effects such as dizziness, headache, edema, urinary disorders, insomnia, and flushing may occur, and in rare cases, severe kidney problems or allergic reactions may also occur. Due to the potential risk of hypotension, blood pressure and electrolyte status should be regularly monitored, particularly in patients on high-dose diuretics who need to be aware of symptoms of low blood pressure. This medication may interact with other antihypertensives, potassium-sparing diuretics, lithium preparations, and non-steroidal anti-inflammatory drugs, so it is critical to inform your healthcare provider of any other medications being taken. Pregnant or breastfeeding women are advised to avoid this medication, and careful consideration should be given in consultation with a healthcare professional if needed. Safety and efficacy in patients under 18 years of age have not been established, so its use is not recommended. Elderly patients may be more sensitive to this medication, so caution is advised when taking it. Patients with moderate to severe liver dysfunction should not take this medication. In case of overdose, severe hypotension and cardiac issues may occur; immediate medical attention should be sought, and emergency treatment may be necessary. This medication should be stored out of reach of children, and transferring it to another container can lead to quality degradation or accidents, which should be avoided.
Urticaria, severe swelling (edema), chest tightness, difficulty breathing, cold sweat, pallor, severe rash with fever, blisters, skin peeling, mouth/eye mucosal pain, wheezing or difficulty breathing, asthma attack, respiratory distress associated with cough and fever, yellowing of skin or eyes (jaundice), extreme lethargy, sudden and severe headache, thunderclap headache, seizure, confusion, visual disturbances, paralysis, urination
Not everyone experiences these, and they can vary from person to person.
This medication is sensitive to light and should be stored in a container that does not allow light to pass through. Additionally, it is important to maintain a temperature between 1 and 30 degrees Celsius when storing the medication to preserve its effectiveness.
White, rounded square film-coated tablets
30 tablets/bottle, 300 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationFimasartan Potassium Trihydrate 33.005mg · S-Amlodipine Besylate 2.5 Hydrate 3.74mg
Tablet · Prescription medication · Combination
Youngpoong Pharmaceutical Co., Ltd.
CombinationFimasartan Potassium Trihydrate 66.01mg · S-Amlodipine Besylate 2.5 Hydrate 7.48mg
Tablet · Prescription medication · Combination
Donggu Bio Pharmaceutical Co., Ltd.
CombinationFimasartan Potassium Trihydrate 33.005mg · S-Amlodipine Besylate 2.5 Hydrate 3.74mg
Tablet · Prescription medication · Combination
Donggu Bio Pharmaceutical Co., Ltd.
CombinationFimasartan Potassium Trihydrate 66.01mg · S-Amlodipine Besylate 2.5 Hydrate 3.74mg
Tablet · Prescription medication · Combination
Donggu Bio Pharmaceutical Co., Ltd.
CombinationFimasartan Potassium Trihydrate 33.005mg · S-Amlodipine Besylate 2.5 Hydrate 3.74mg
Tablet · Prescription medication · Combination
NBK Pharmaceutical Co., Ltd.
CombinationFimasartan Potassium Trihydrate 33.005mg · S-Amlodipine Besylate 2.5 Hydrate 3.74mg
Tablet · Prescription medication · Combination
Ajou Pharmaceuticals Co., Ltd.
CombinationFimasartan Potassium Trihydrate 33.005mg · S-Amlodipine Besylate 2.5 Hydrate 3.74mg
Tablet · Prescription medication · Combination
Kips Biopharma Co., Ltd.
CombinationFimasartan Potassium Trihydrate 33.005mg · S-Amlodipine Besylate 2.5 Hydrate 3.74mg
Tablet · Prescription medication · Combination
Bionex Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.